Zhu Yan, Chen Yu-ling, Li Cong, Ding Xiao-yan, Xu Guo-yu, Hu Li-li, Hou Fan-fan, Zhou Qiu-gen
Division of Nephrology, Nanfang Hospital, Southern Medical University; Key Lab of Organ Failure, Ministry of Education; Guangzhou 510515, China.
Acta Pharmacol Sin. 2014 Mar;35(3):356-62. doi: 10.1038/aps.2013.177. Epub 2014 Jan 20.
Lipolysis in fat tissue plays an important role in the development of metabolic disturbances, a characteristic feature of chronic kidney disease (CKD). In the present study, we tested the hypothesis that the inhibition of endoplasmic reticulum (ER) stress could alleviate lipolysis in white adipose tissue in a rat model of CKD.
A rat model of CKD was established by a method of reduced renal mass (RRM). Lipolysis was measured as the release of glycerol in ex vivo fat pads and cultured primary adipocytes. The activity of lipases and markers of ER stress were measured by Western blotting and immunoprecipitation.
Our data showed that lipolysis in visceral white adipose tissue was increased in RRM rats compared with control rats. In addition, increased phosphorylation of hormone-sensitive lipase (HSL) and binding of adipose triglyceride lipase (ATGL) to comparative gene identification-58 (CGI-58) protein were observed in the RRM rats. The phosphorylation of ER stress markers, including IRE1α, PERK, and eukaryotic initiation factor (eIF) 2α, and the expression of ER stress marker 78 kDa glucose-regulated protein (GRP78) were significantly increased in RRM rats. Treatment with an inhibitor of ER stress partially but significantly alleviated lipolysis, and this alleviation was accompanied by reduced binding of ATGL to CGI-58.
Our results showed that enhanced lipolysis and ER stress occurred in visceral white adipose tissue in a rat model of CKD. Moreover, inhibition of ER stress significantly alleviated lipolysis. These findings suggest that ER stress is a potential therapeutic target for the metabolic disturbances associated with CKD.
脂肪组织中的脂解作用在代谢紊乱的发展过程中起着重要作用,而代谢紊乱是慢性肾脏病(CKD)的一个特征性表现。在本研究中,我们验证了内质网(ER)应激的抑制可减轻CKD大鼠模型白色脂肪组织中脂解作用的这一假说。
采用减少肾质量(RRM)的方法建立CKD大鼠模型。通过离体脂肪垫和原代培养脂肪细胞中甘油的释放来测定脂解作用。采用蛋白质免疫印迹法和免疫沉淀法测定脂肪酶活性和ER应激标志物。
我们的数据显示,与对照大鼠相比,RRM大鼠内脏白色脂肪组织中的脂解作用增强。此外,在RRM大鼠中观察到激素敏感性脂肪酶(HSL)的磷酸化增加以及脂肪甘油三酯脂肪酶(ATGL)与比较基因识别-58(CGI-58)蛋白的结合增加。RRM大鼠中ER应激标志物包括肌醇需求酶1α(IRE1α)、蛋白激酶RNA样内质网激酶(PERK)和真核起始因子(eIF)2α的磷酸化以及ER应激标志物78 kDa葡萄糖调节蛋白(GRP78)的表达均显著增加。用ER应激抑制剂治疗可部分但显著减轻脂解作用,且这种减轻伴随着ATGL与CGI-58结合的减少。
我们的结果表明,在CKD大鼠模型的内脏白色脂肪组织中,脂解作用增强且ER应激发生。此外,抑制ER应激可显著减轻脂解作用。这些发现提示,ER应激是与CKD相关的代谢紊乱的一个潜在治疗靶点。